Coordinated Action on Viral Hepatitis (AC45)

Objectives of the Coordinated Action

CA45’s activity is structured around two main areas: scientific coordination and project support.

To this end, it has set itself four objectives:

• scientific coordination in the fields of clinical and translational research and human and social sciences on viral hepatitis and its comorbidities, in France and internationally;
• the development of collaborations and the creation of working groups on research priorities;
• support for researchers in the design and development of projects for submission to calls for projects from ANRS MIE or other national and international funding bodies;
• and the scientific promotion of research in the form of symposiums, conferences and publications.

Co-chairs

Working groups

Prevention, screening and access to care working group

Coordination:

• François BAILLY (Hepatology and Gastroenterology Department, Croix-Rousse Hospital/Lyon University Hospital)
• Moana GELU-SIMEON (Hepatology and Gastroenterology Department, Guadeloupe University Hospital)

Hepatitis B and D Treatment WG

Coordination:

• Vincent LEROY (Hepatology Department, Henri Mondor Hospital)
• Fabien ZOULIM (Lyon Cancer Research Centre, UMR Inserm 1052)

Members:

• Marc BOURLIERE (Saint-Joseph Hospital, Marseille)
• Ségolène BRICHLER (Avicenne University Hospital / AP-HP)
• Marie-Noëlle HILLERET (Grenoble University Hospital)
• Patrick INGILIZ (Henri-Mondor Hospital)
• Véronique LOUSTAUD-RATTI (Limoges University Hospital)
• Lucia PARLATI (Cochin Hospital)
• Antonio SAVIANO (Strasbourg University Hospital)
• Caroline SCHOLTES (Lyon University Hospital / Inserm / CRCL)
• Vincent THIBAULT (Rennes University Hospital)
• François VILLERET (Lyon University Hospital)

Natural History and Comorbidities Working Group

Coordination:

• Jérôme BOURSIER (Hepatology and Gastroenterology Department, Angers University Hospital)
• Laure ELKRIEF (Hepatology and Gastroenterology Department, Trousseau Hospital / Tours University Hospital)

Working Group on Specificities of the South

Coordination:

• Maud LEMOINE (Hepatology Department, St Mary’s Imperial College Hospital, London, United Kingdom)
• Servais Albert ELOUMOU BAGNAKA (Internal Medicine Department, Gynaecology, Obstetrics and Paediatrics Hospital, Douala, Cameroon)

ANRS MIE Coordination

• Chloé DUQUESNAY – Scientific Coordinator
• Mickael HNEINO – Project Manager
• Ventzislava PETROV SANCHEZ – Head of Clinical Research Department